NT-proBNP for heart failure diagnosis in Primary Care: Costs or savings? A budget impact study

NT-proBNP for heart failure diagnosis in Primary Care: Costs or savings? A budget impact study

Introduction and objectives: Chronic heart failure (CHF) is a growing public health concern and diagnosis can be challenging, particularly in primary care. This study aims to estimate the budgetary impact of introducing N-terminal pro-B-type natriuretic peptide (NT-proBNP) for CHF diagnosis in a pri...

Full description

Bibliographic Details
Main Authors:	Cândida Fonseca, Paulo Bettencourt, Dulce Brito, Helena Febra, Álvaro Pereira, Victória Genovez, Nelson Lopes
Format:	Article
Language:	English
Published:	Elsevier 2022-03-01
Series:	Revista Portuguesa de Cardiologia
Subjects:	Insuficiência cardíaca crónica Diagnóstico Cuidados de Saúde Primários Biomarcadores Péptidos natriuréticos NT-proBNP
Online Access:	http://www.sciencedirect.com/science/article/pii/S0870255121003619

Similar Items

NT-proBNP como factor pronóstico de mortalidad en pacientes hospitalizados por COVID-19 durante el periodo enero-octubre 2021
by: Edgardo Parucho, et al.
Published: (2023-02-01)

NT-proBNP como factor pronóstico de mortalidad en pacientes hospitalizados por COVID-19 durante el periodo enero-octubre 2021
by: Edgardo Parucho, et al.
Published: (2023-02-01)

Relação entre depressão, nível de BNP e comprometimento ventricular na insuficiência cardíaca
by: Vera Barretto Aguiar, et al.
Published: (2010-12-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)

Comparação entre BNP e NT-proBNP quanto à concordância e quanto à influência das variáveis clínicas e laboratoriais
by: Milena Novaes Cardoso Curiati, et al.

NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
by: Stefano Ciardullo, et al.
Published: (2022-11-01)

The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic
by: Lucian MURESAN, et al.
Published: (2017-06-01)

Significance of NT-proBNP and High-Sensitivity Troponin in Friedreich Ataxia
by: Lise Legrand, et al.
Published: (2020-05-01)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
by: Brian Kerr, et al.
Published: (2022-12-01)

Prognostic value of the combination of uric acid and NT-proBNP in patients with chronic heart failure
by: Gülsüm Meral Yılmaz Öztekin, et al.
Published: (2022-05-01)

Prognostic of NT-proBNP in heart failure patients with preserved, mid and reduced ejection fraction
by: Reynie Leonel Reinoso Gonella, et al.
Published: (2021-10-01)

Relationship of plasma level of NT- ProBNP with development of AF in CABG patients
by: Tanaray B, et al.
Published: (2010-10-01)

La precisión diagnóstica de los péptidos natriuréticos en la insuficiencia cardiaca: una revisión sistemática y metaanálisis en el paciente agudo
by: Alberto Hernández
Published: (2015-11-01)

Inhibición dual de la neprilisina y el receptor de angiotensina II: nueva estrategia prometedora en el tratamiento de la enfermedad cardiovascular
by: Fernando Manzur, et al.
Published: (2013-12-01)

Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study
by: Sonja Levy, et al.
Published: (2022-05-01)

Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
by: Hussein Alawieh, et al.
Published: (2019-11-01)

LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
by: Maria António, et al.
Published: (2023-07-01)

Diagnostic value of NT–PRO BNP in cardiogenic and non cardiogenic pleural effusions
by: Mohamed E. Abdalla, et al.
Published: (2012-07-01)

Changes in Cardiac Levels of Caspase-8, Bcl-2 and NT-proBNP Following 4 Weeks of Aerobic Exercise in Diabetic Rats
by: Saeid Tanoorsaz, et al.
Published: (2017-12-01)

Influence of collaterals on the left ventricular end-diastolic pressure and serum NT-proBNP levels in patients with coronary chronic total occlusion
by: Fuad Samadov, et al.
Published: (2017-06-01)

NT-proBNP Concentrations in the Umbilical Cord and Serum of Term Neonates: A Systematic Review and Meta-Analysis
by: Evangelos Christou, et al.
Published: (2022-06-01)

Development of a Rapid Diagnostic Kit for Congestive Heart Failure Using Recombinant NT-proBNP Antigen
by: Young-Ki Lee, et al.
Published: (2021-07-01)

Síndrome Hiperinflamatória como Mecanismo de Lesão Cardíaca
by: Silvia Moreira Ayub-Ferreira, et al.
Published: (2021-04-01)

Relação entre depressão, nível de BNP e comprometimento ventricular na insuficiência cardíaca Relación entre depresión, nivel de bnp y compromiso ventricular en la insuficiencia cardíaca Relationship between depression, BNP levels and ventricular impairment in heart failure
by: Vera Barretto Aguiar, et al.
Published: (2010-12-01)

Prognostic value of perioperative NT-proBNP after corrective surgery for pediatric congenital heart defects
by: Fangqin Lin, et al.
Published: (2019-12-01)

Paper Biosensor for the Detection of NT-proBNP Using Silver Nanodisks as Electrochemical Labels
by: Yi Peng, et al.
Published: (2022-06-01)

NT-proBNP as predictor of major cardiac events after renal transplantation in patients with preserved left ventricular ejection fraction
by: Sebastian Schwab, et al.
Published: (2023-02-01)

Relationship between NT-proBNP and the ejection fraction during intensive care variety in polytrauma patients with concomitant cardiac disorder
by: Svitlana Lutska, et al.
Published: (2021-10-01)

RETRACTED: N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-proBNP) IN STAGE 1 AND STAGE 2 HYPERTENSION PATIENTS
by: Supriati Wila Djami
Published: (2019-10-01)

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis
by: Stefanie Hendricks, et al.
Published: (2022-10-01)

Correlation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) with radiographic features of congestion in chest CT scan of patients with COVID-19
by: Naghmeh Ziaie, et al.
Published: (2023-07-01)

NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
by: Claire Sweeney, et al.
Published: (2021-12-01)

miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
by: Jan-Thorben Sieweke, et al.
Published: (2020-04-01)

N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes
by: C. Mady, et al.
Published: (2008-08-01)

Association of Paraoxonase-1 and NT-proBNP with Clinical, Clinico-Pathologic and Echocardiographic Variables in Dogs with Mitral Valve Disease
by: Diana Rammal, et al.
Published: (2023-01-01)

Optimal cut points of N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) in patients with COVID-19
by: Mohammad Chehrazi, et al.
Published: (2022-03-01)

Correlation between NT-proBNP plasma levels with mitral annular Tissue Doppler Velocities in Heart Failure patients
by: Raja Adil C Siregar, et al.
Published: (2013-06-01)

Cardiac effects of positive pressure ventilation in ARDS assessed by NT-proBNP, Troponin T and Troponin I
by: Yasser Sadek Nassar, et al.
Published: (2013-01-01)

Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
by: Noelia Costa-Rodríguez, et al.
Published: (2023-08-01)

The cost‐effectiveness of NT‐proBNP for assessment of suspected acute heart failure in the emergency department
by: Ryan Walkley, et al.
Published: (2023-12-01)